1-(4-Chlorophenyl)-2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)ethan-1-one hydrobromide

Catalog No. :
ACGHBO281
CAS No. :
63208-80-0
Molecular Formula :
C15H16BrClN2OS
Molecular Weight :
387.73

IUPAC Name:1-(4-chlorophenyl)-2-(2-imino-4,5,6,7-tetrahydrobenzo[d]thiazol-3(2H)-yl)ethan-1-one hydrobromide

1-(4-Chlorophenyl)-2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)ethan-1-one hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg90%$121.00Login to see priceInquiryInquiry
10mg90%$148.00Login to see priceInquiryInquiry
50mg90%$209.00Login to see priceInquiryInquiry
100mg90%$275.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chlorophenyl)-2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)ethan-1-one hydrobromide
IUPAC Name1-(4-chlorophenyl)-2-(2-imino-4,5,6,7-tetrahydrobenzo[d]thiazol-3(2H)-yl)ethan-1-one hydrobromide
Molecular FormulaC15H16BrClN2OS
Molecular Weight387.73
SMILESO=C(C1=CC=C(Cl)C=C1)CN2C(SC3=C2CCCC3)=N.[H]Br
InChI KeyUOUQIPOYIWHTBD-UHFFFAOYSA-N
Synonym1-(4-chlorophenyl)-2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)ethan-1-one hydrobromide
CAS No.63208-80-0

Synthetic Route by SureRoute

1. ACGHBO281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYZOS586 route compound structure diagram
    ACYZOS5862933-29-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHBO281 route product structure diagram
    ACGHBO28163208-80-0
Inquiry

2. ACGHBO281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYZOS586 route compound structure diagram
    ACYZOS5862933-29-1 In Stock
  2. Plus
  3. ACPWEN473 route compound structure diagram
    ACPWEN473937-20-2 In Stock
  4. Then
  5. ACGHBO281 route product structure diagram
    ACGHBO28163208-80-0
Inquiry

Comments (0)